Familial Amyloid Polyneuropathy Therapeutic and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Familial Amyloid Polyneuropathy Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Drug Type
1.2.2 Market by Application
1.3 Global Familial Amyloid Polyneuropathy Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Familial Amyloid Polyneuropathy Therapeutic Overall Market Size
2.1 Global Familial Amyloid Polyneuropathy Therapeutic Market Size: 2022 VS 2030
2.2 Global Familial Amyloid Polyneuropathy Therapeutic Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Familial Amyloid Polyneuropathy Therapeutic Players in Global Market
3.2 Top Global Familial Amyloid Polyneuropathy Therapeutic Companies Ranked by Revenue
3.3 Global Familial Amyloid Polyneuropathy Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Familial Amyloid Polyneuropathy Therapeutic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Familial Amyloid Polyneuropathy Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Therapeutic Players in Global Market
3.6.1 List of Global Tier 1 Familial Amyloid Polyneuropathy Therapeutic Companies
3.6.2 List of Global Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Therapeutic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Drug Type - Global Familial Amyloid Polyneuropathy Therapeutic Market Size Markets, 2022 & 2030
4.1.2 Inotersen
4.1.3 Tafamidis
4.1.4 Patisiran
4.1.5 Others
4.2 By Drug Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue & Forecasts
4.2.1 By Drug Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2023
4.2.2 By Drug Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2023-2030
4.2.3 By Drug Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2023
5.2.2 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2023-2030
5.2.3 By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Market Size, 2022 & 2030
6.2 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2023
6.2.2 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2023-2030
6.2.3 By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2030
6.3.2 US Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.3.3 Canada Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.3.4 Mexico Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2030
6.4.2 Germany Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4.3 France Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4.4 U.K. Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4.5 Italy Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4.6 Russia Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4.7 Nordic Countries Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.4.8 Benelux Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2030
6.5.2 China Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.5.3 Japan Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.5.4 South Korea Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.5.5 Southeast Asia Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.5.6 India Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2030
6.6.2 Brazil Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.6.3 Argentina Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2030
6.7.2 Turkey Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.7.3 Israel Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.7.4 Saudi Arabia Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
6.7.5 UAE Familial Amyloid Polyneuropathy Therapeutic Market Size, 2018-2030
7 Players Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporate Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.1.4 Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News
7.2 Alnylam Pharmaceuticals Inc.
7.2.1 Alnylam Pharmaceuticals Inc. Corporate Summary
7.2.2 Alnylam Pharmaceuticals Inc. Business Overview
7.2.3 Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Inc. Key News
7.3 Ionis Pharmaceuticals Inc.
7.3.1 Ionis Pharmaceuticals Inc. Corporate Summary
7.3.2 Ionis Pharmaceuticals Inc. Business Overview
7.3.3 Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.3.4 Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.3.5 Ionis Pharmaceuticals Inc. Key News
7.4 Corino Therapeutics Inc.
7.4.1 Corino Therapeutics Inc. Corporate Summary
7.4.2 Corino Therapeutics Inc. Business Overview
7.4.3 Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.4.4 Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.4.5 Corino Therapeutics Inc. Key News
7.5 Proclara Biosciences
7.5.1 Proclara Biosciences Corporate Summary
7.5.2 Proclara Biosciences Business Overview
7.5.3 Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.5.4 Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.5.5 Proclara Biosciences Key News
7.6 Arcturus Therapeutics Inc
7.6.1 Arcturus Therapeutics Inc Corporate Summary
7.6.2 Arcturus Therapeutics Inc Business Overview
7.6.3 Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Major Product Offerings
7.6.4 Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Revenue in Global Market (2018-2023)
7.6.5 Arcturus Therapeutics Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Familial Amyloid Polyneuropathy Therapeutic Market Opportunities & Trends in Global Market
Table 2. Familial Amyloid Polyneuropathy Therapeutic Market Drivers in Global Market
Table 3. Familial Amyloid Polyneuropathy Therapeutic Market Restraints in Global Market
Table 4. Key Players of Familial Amyloid Polyneuropathy Therapeutic in Global Market
Table 5. Top Familial Amyloid Polyneuropathy Therapeutic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Familial Amyloid Polyneuropathy Therapeutic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Familial Amyloid Polyneuropathy Therapeutic Product Type
Table 9. List of Global Tier 1 Familial Amyloid Polyneuropathy Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Familial Amyloid Polyneuropathy Therapeutic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Drug Type ? Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2030
Table 12. By Drug Type - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Drug Type - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Familial Amyloid Polyneuropathy Therapeutic Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2023-2030
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 32. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), (2018-2023)
Table 33. Alnylam Pharmaceuticals Inc. Corporate Summary
Table 34. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 35. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), (2018-2023)
Table 36. Ionis Pharmaceuticals Inc. Corporate Summary
Table 37. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 38. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), (2018-2023)
Table 39. Corino Therapeutics Inc. Corporate Summary
Table 40. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 41. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), (2018-2023)
Table 42. Proclara Biosciences Corporate Summary
Table 43. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 44. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), (2018-2023)
Table 45. Arcturus Therapeutics Inc Corporate Summary
Table 46. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Product Offerings
Table 47. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Familial Amyloid Polyneuropathy Therapeutic Segment by Drug Type in 2022
Figure 2. Familial Amyloid Polyneuropathy Therapeutic Segment by Application in 2022
Figure 3. Global Familial Amyloid Polyneuropathy Therapeutic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Familial Amyloid Polyneuropathy Therapeutic Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Familial Amyloid Polyneuropathy Therapeutic Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Familial Amyloid Polyneuropathy Therapeutic Revenue in 2022
Figure 8. By Drug Type - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 9. By Application - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 10. By Region - Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 11. By Country - North America Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 12. US Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 16. Germany Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 17. France Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 24. China Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 28. India Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 30. Brazil Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share, 2018-2030
Figure 33. Turkey Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Familial Amyloid Polyneuropathy Therapeutic Revenue, (US$, Mn), 2018-2030
Figure 37. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
